168 related articles for article (PubMed ID: 20885773)
21. Glyburide and tolbutamide induce desensitization of insulin release in rat pancreatic islets by different mechanisms.
Rabuazzo AM; Buscema M; Vinci C; Caltabiano V; Vetri M; Forte F; Vigneri R; Purrello F
Endocrinology; 1992 Oct; 131(4):1815-20. PubMed ID: 1396327
[TBL] [Abstract][Full Text] [Related]
22. Effect of dynorphin on insulin and somatostatin secretion, calcium uptake, and c-AMP levels in isolated rat islets of Langerhans.
Green IC; Perrin D; Penman E; Yaseen A; Ray K; Howell SL
Diabetes; 1983 Aug; 32(8):685-90. PubMed ID: 6135634
[TBL] [Abstract][Full Text] [Related]
23. The somatostatin receptor in human pancreatic β-cells.
Braun M
Vitam Horm; 2014; 95():165-93. PubMed ID: 24559918
[TBL] [Abstract][Full Text] [Related]
24. The ionic, electrical, and secretory effects of endogenous cyclic adenosine monophosphate in mouse pancreatic B cells: studies with forskolin.
Henquin JC; Meissner HP
Endocrinology; 1984 Sep; 115(3):1125-34. PubMed ID: 6086286
[TBL] [Abstract][Full Text] [Related]
25. Effects of prolonged exposure to pancreatic glucagon on the function, antigenicity and survival of isolated human islets.
Del Guerra S; Lupi R; Dotta F; Marselli L; Lencioni C; Santangelo C; Realacci M; Carmellini M; Mosca F; Navalesi R; Marchetti P
Diabetes Metab Res Rev; 2000; 16(4):281-6. PubMed ID: 10934457
[TBL] [Abstract][Full Text] [Related]
26. Glucose suppression of glucagon secretion: metabolic and calcium responses from alpha-cells in intact mouse pancreatic islets.
Le Marchand SJ; Piston DW
J Biol Chem; 2010 May; 285(19):14389-98. PubMed ID: 20231269
[TBL] [Abstract][Full Text] [Related]
27. Glucose controls glucagon secretion by directly modulating cAMP in alpha cells.
Yu Q; Shuai H; Ahooghalandari P; Gylfe E; Tengholm A
Diabetologia; 2019 Jul; 62(7):1212-1224. PubMed ID: 30953108
[TBL] [Abstract][Full Text] [Related]
28. Glucose inhibition of glucagon secretion from rat alpha-cells is mediated by GABA released from neighboring beta-cells.
Wendt A; Birnir B; Buschard K; Gromada J; Salehi A; Sewing S; Rorsman P; Braun M
Diabetes; 2004 Apr; 53(4):1038-45. PubMed ID: 15047619
[TBL] [Abstract][Full Text] [Related]
29. CART is overexpressed in human type 2 diabetic islets and inhibits glucagon secretion and increases insulin secretion.
Abels M; Riva M; Bennet H; Ahlqvist E; Dyachok O; Nagaraj V; Shcherbina L; Fred RG; Poon W; Sörhede-Winzell M; Fadista J; Lindqvist A; Kask L; Sathanoori R; Dekker-Nitert M; Kuhar MJ; Ahrén B; Wollheim CB; Hansson O; Tengholm A; Fex M; Renström E; Groop L; Lyssenko V; Wierup N
Diabetologia; 2016 Sep; 59(9):1928-37. PubMed ID: 27338624
[TBL] [Abstract][Full Text] [Related]
30. Glucose-dependent insulinotropic polypeptide is expressed in pancreatic islet alpha-cells and promotes insulin secretion.
Fujita Y; Wideman RD; Asadi A; Yang GK; Baker R; Webber T; Zhang T; Wang R; Ao Z; Warnock GL; Kwok YN; Kieffer TJ
Gastroenterology; 2010 May; 138(5):1966-75. PubMed ID: 20138041
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of arachidonate release by secretagogue-stimulated pancreatic islets suppresses both insulin secretion and the rise in beta-cell cytosolic calcium ion concentration.
Ramanadham S; Gross RW; Han X; Turk J
Biochemistry; 1993 Jan; 32(1):337-46. PubMed ID: 8418854
[TBL] [Abstract][Full Text] [Related]
32. Mouse pancreatic beta-cells exhibit preserved glucose competence after disruption of the glucagon-like peptide-1 receptor gene.
Flamez D; Van Breusegem A; Scrocchi LA; Quartier E; Pipeleers D; Drucker DJ; Schuit F
Diabetes; 1998 Apr; 47(4):646-52. PubMed ID: 9568699
[TBL] [Abstract][Full Text] [Related]
33. Evidence for the participation of calmodulin in stimulus-secretion coupling in the pancreatic beta-cell.
Gagliardino JJ; Harrison DE; Christie MR; Gagliardino EE; Ashcroft SJ
Biochem J; 1980 Dec; 192(3):919-27. PubMed ID: 6263264
[TBL] [Abstract][Full Text] [Related]
34. Evidence for inhibitory autocrine effects of proinsulin C-peptide on pancreatic β-cell function and insulin secretion.
McKillop AM; Ng MT; Abdel-Wahab YH; Flatt PR
Diabetes Obes Metab; 2014 Oct; 16(10):937-46. PubMed ID: 24702738
[TBL] [Abstract][Full Text] [Related]
35. Islet distribution of Peptide YY and its regulatory role in primary mouse islets and immortalised rodent and human beta-cell function and survival.
Khan D; Vasu S; Moffett RC; Irwin N; Flatt PR
Mol Cell Endocrinol; 2016 Nov; 436():102-13. PubMed ID: 27465830
[TBL] [Abstract][Full Text] [Related]
36. Glucose-induced cAMP elevation in β-cells involves amplification of constitutive and glucagon-activated GLP-1 receptor signalling.
Shuai H; Xu Y; Ahooghalandari P; Tengholm A
Acta Physiol (Oxf); 2021 Apr; 231(4):e13611. PubMed ID: 33369112
[TBL] [Abstract][Full Text] [Related]
37. Somatostatin: mechanism of action in pancreatic islet beta-cells.
Pace CS; Tarvin JT
Diabetes; 1981 Oct; 30(10):836-42. PubMed ID: 6115784
[TBL] [Abstract][Full Text] [Related]
38. Structure-function relationships in pancreatic islets: support for intraislet modulation of insulin secretion.
Hopcroft DW; Mason DR; Scott RS
Endocrinology; 1985 Nov; 117(5):2073-80. PubMed ID: 2864239
[TBL] [Abstract][Full Text] [Related]
39. Altered pancreatic islet morphology and function in SGLT1 knockout mice on a glucose-deficient, fat-enriched diet.
Mühlemann M; Zdzieblo D; Friedrich A; Berger C; Otto C; Walles H; Koepsell H; Metzger M
Mol Metab; 2018 Jul; 13():67-76. PubMed ID: 29859847
[TBL] [Abstract][Full Text] [Related]
40. Islet amyloid polypeptide tonally inhibits beta-, alpha-, and delta-cell secretion in isolated rat pancreatic islets.
Wang F; Adrian TE; Westermark GT; Ding X; Gasslander T; Permert J
Am J Physiol; 1999 Jan; 276(1):E19-24. PubMed ID: 9886946
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
